Card Tech Minutes 2013.01.09

From IHE Wiki
Jump to: navigation, search

Attendees

  • Alan Katz - ACC
  • Antje Schroeder - Siemens
  • Barry Brown - Mortara
  • Chris Melo - Philips
  • Paul Dow - ACC
  • Paul Seifert - Agfa
  • Paul Varghese - Agfa
  • Tom Dolan - Philips

Meeting Notes

  • ACC provides two different methods of Surveys:
    • General survey for MDs (6-8 Q) asking broad questions about challenges faced by clinicians and how IHE can improve care delivery. (no cost to IHE, will take 1-2 weeks to execute, March earliest time frame)
    • Deeper dive (15-20 Q) w/ hospital execs to show the value of IHE solutions to their larger organizations. (cost will vary depending on target demographic, survey tool [on-line vs. phone] will take 6-8 weeks to execute, March or April earliest time frame)
  • The decision was to start with the general survey and create the more detailed one based on the results of the general survey
  • Draft questionaire, that was shared with Planning Committee prior to review with ACC Survey group
  1. How important is multiple-vendor Interoperability to you in cardiology workflow
    1. critical – it’s one of the top 5 selection criteria and is a deal-breaker
    2. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
    3. medium - it always there and considered
    4. low – it never really comes up
  2. What are key interoperability pain points that you experience today - please specify
  3. What is your role in Cardiology IT purchasing decisions
    1. Decision maker, member of decision making unit
    2. Decision influencer – consulted by decision makers
    3. None
  4. How important is multiple-vendor Interoperability to you in cardiology IT purchasing decisions
    1. critical – it’s one of the top 5 selection criteria and is a deal-breaker
    2. high – it’s very important and always comes up, but not a buy/not-buy dealbreaker
    3. medium - it always there and considered
    4. low – it never really comes up
  5. Are you aware of IHE (Integrating the Healthcare Enterprise)
    1.  ? never heard of it
    2. Somewhat familiar
    3. Very familiar – continually use it in my discussion on cardiology Interoperability
  6. If yes - describe its role in addressing your interoperability concerns
    1. Very Valuable – please mention specific profiles used
    2. Not Available – vendors do not have requested profiles or only incomplete support
      1. Please illustrate
    3. Not fully applicable - it has gaps which doesn’t address my key concerns – please specify
  7. Would you like a follow-up to find out more information?
    1. Contact method ( phone/email)
    2. no